Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.29 USD | -2.76% | -7.62% | -29.98% |
12-06 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
12-06 | Health insurer shares fall after UnitedHealth exec murder | RE |
Capitalization | 69.58B 65.84B 61.04B 54.58B 98.37B 5,892B 109B 759B 281B 2,421B 261B 256B 10,431B | P/E ratio 2024 * |
18x | P/E ratio 2025 * | 10.6x |
---|---|---|---|---|---|
Enterprise value | 122B 116B 107B 96.1B 173B 10,374B 192B 1,337B 494B 4,262B 460B 450B 18,365B | EV / Sales 2024 * |
0.33x | EV / Sales 2025 * | 0.31x |
Free-Float |
70.71% | Yield 2024 * |
4.79% | Yield 2025 * | 4.47% |
Last Transcript: CVS Health Corporation
1 day | +0.29% | ||
1 week | -7.62% | ||
Current month | -7.62% | ||
1 month | -10.26% | ||
3 months | -4.26% | ||
6 months | -9.27% | ||
Current year | -29.98% |
Director | Title | Age | Since |
---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 60 | 16/10/2024 |
Prem Shah
PSD | President | - | 05/11/2024 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 12/10/2023 |
Manager | Title | Age | Since |
---|---|---|---|
C. Brown
BRD | Director/Board Member | 72 | 28/02/2007 |
Director/Board Member | 73 | 28/02/2007 | |
Anne Finucane
BRD | Director/Board Member | 71 | 19/01/2011 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.92% | 20 M€ | +16.75% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-2.76% | -7.62% | -24.78% | -40.32% | 69.58B | ||
-0.09% | -2.28% | +26.69% | +36.78% | 80.99B | ||
+1.26% | +7.46% | +1.91% | +76.81% | 26.85B | ||
+1.56% | +2.31% | +196.46% | +98.99% | 22.66B | ||
-0.88% | +1.20% | +16.91% | -2.35% | 20.04B | ||
-0.99% | -3.56% | +6.75% | -19.60% | 19.45B | ||
-0.74% | -3.26% | +16.62% | -0.18% | 17.56B | ||
0.00% | +9.88% | +22.45% | -18.02% | 14.17B | ||
-0.69% | -3.56% | +53.85% | +56.95% | 13.14B | ||
+0.03% | -2.62% | +100.03% | +91.30% | 13.21B | ||
Average | -0.02% | -0.18% | +41.69% | +28.04% | 29.77B | |
Weighted average by Cap. | +0.08% | -1.69% | +27.05% | +19.31% |
2024 * | 2025 * | |
---|---|---|
Net sales | 372B 352B 326B 292B 526B 31,494B 582B 4,059B 1,501B 12,940B 1,397B 1,366B 55,754B | 387B 366B 339B 303B 547B 32,760B 605B 4,222B 1,561B 13,460B 1,453B 1,421B 57,995B |
Net income | 4.3B 4.06B 3.77B 3.37B 6.07B 364B 6.72B 46.88B 17.33B 149B 16.13B 15.78B 644B | 6.64B 6.28B 5.82B 5.21B 9.39B 562B 10.39B 72.47B 26.79B 231B 24.94B 24.39B 995B |
Net Debt | 52.92B 50.07B 46.42B 41.51B 74.81B 4,481B 82.82B 578B 214B 1,841B 199B 194B 7,933B | 50.18B 47.49B 44.02B 39.37B 70.95B 4,250B 78.54B 548B 203B 1,746B 189B 184B 7,524B |
Date | Price | Change | Volume |
---|---|---|---|
06/12/24 | 55.29 $ | -2.76% | 9,635,184 |
05/12/24 | 56.86 $ | -2.05% | 9,063,465 |
04/12/24 | 58.05 $ | -1.93% | 7,953,786 |
03/12/24 | 59.19 $ | +0.19% | 9,011,484 |
02/12/24 | 59.08 $ | -1.29% | 11,633,673 |
Delayed Quote Nyse, December 06, 2024 at 09:00 pm
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- CVS Stock
MarketScreener is also available in this country: United States.
Switch edition